Epidemiology and Demography
A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia.Lucinde RK
Gathuri H
Mwaniki P
Orindi B
Otieno EO
Mwakio S
Mulemi L
Isaaka L
Shangala J
Saisi M
Isinde E
Oginga IN
Wachira AW
Manuthu E
Kariuki H
Asaava P
Nyikuli J
Wekesa C
Otedo A
Bosire H
Okoth SB
Ongalo W
Mukabi DM
Lusamba W
Muthui B
Adembesa I
Mithi C
Sood M
Aliyan NA
Gituma B
Matiko MG
Omondi CA
Ombajo LA
Kirui N
Ochola L
Abdi AI
Kagucia EW
English M
Hamaluba M
Ochola-Oyier I
Kamuya D
Bejon P
Barasa E
Agweyu A
Akech S
Etyang AO
N Engl J Med, (2025). 393:2187-2197
Plasma folate dynamics in Plasmodium falciparum-infected African children treated with artemisinin combination therapy and single low-dose primaquine or placebo.Ajayi S
Onyamboko MA
Olupot-Olupot P
Ayuen DS
Chimjinda N
Taya C
Williams TN
Uyoga S
Maitland K
Fanello C
Day NPJ
Mukaka M
Taylor WRJ
Malar J, (2025). 24:342
Assessing the Impact of SARS-CoV-2 Spike Mutations on Antibody Binding: A Comparative Assessment of the Wuhan and JN.1 Variants' Full-Length Spikes in a Multiplex Luminex Assay.Waweru G
Nyakundi R
Kutima B
Owuor S
Konyino G
Gitonga J
Lugano D
Maina A
Musyoki J
Ochola L
Omondi M
Kariuki CK
Ogongo P
Mwachari C
Shee F
Agoti C
Sande C
Uyoga S
Kagucia E
Agweyu A
Bejon P
Scott JAG
Warimwe GM
Ochola-Oyier LI
Nyagwange J
Viruses, (2025). 17:
Modelling the relative contribution of infection, routine vaccination and supplementary immunisation activities to measles seroconversion in Kenyan Children.Mburu C
Ojal J
Selim R
Ombati R
Akech D
Karia B
Tuju J
Sigilai A
Smits G
Gageldonk PV
Klis FV
Kagucia E
Scott A
Adetifa I
Flasche S
PLoS Comput Biol, (2025). 21:e1013531
Genomic and clinical epidemiology of SARS-CoV-2 in coastal Kenya: insights into variant circulation, reinfection, and multiple lineage importations during a post-pandemic wave.Lambisia AW
Katama EN
Moraa E
Mwita JM
Gallagher K
Mutunga M
Nyale E
Omungala J
Mwanga M
Murunga N
Nyiro J
Nyagwange J
Sande C
Bejon P
Githinji G
Dellicour S
Phan MVT
Cotten M
Ochola-Oyier LI
Holmes EC
Agoti CN
BMC Glob Public Health, (2025). 3:80
Cryptosporidium parvum virus 1 genome sequences from pediatric diarrhea cases in coastal Kenya.Agoti CN
Njeru R
Mwanga M
Mutunga M
Shah SP
Chu TY
Nokes DJ
Cotten M
Phan MVT
Microbiol Resour Announc, (2025). 14:e0034925
Epidemiological dynamics of influenza B virus across multiple seasons in Kenya and Uganda inferred from sequence data, 2010-2021.Nyarango BK
Owuor DC
Isoe E
Mutunga M
Cheruiyot R
Katama EN
Makori T
Lambisia A
Nyiro J
Githinji G
Kiguli S
Olupot-Olupot P
Maitland K
Agoti CN
BMC Infect Dis, (2025). 25:1080
Perceived accuracy and utilisation of DHIS2 data for health decision making and advocacy in Kenya: A Qualitative Study.Oware PM
Omondi G
Adipo C
Adow M
Wanyama C
Odallo D
Bosire N
Okong'o L
Maina M
Aluvaala J
Ngwatu P
Githanga D
Kinuthia D
Amadi I
Rukwaro G
Kerubo L
Amisi C
Govoga A
Karimi J
Kahtra A
Mulwa A
Amoth P
Agweyu A
Were F
PLOS Glob Public Health, (2025). 5:e0004508
Retaining African networks is urgent for global health.Bhiman JN
Serwanga J
Ugwu CA
Vigan-Womas I
Quashie PK
Bhattacharya J
Sande C
Bonomo A
Markey FB
Awandare GA
Garg PK
Kaleebu P
Happi C
Rennergarbe A
Woods C
Kirchner J
Aguilar AO
Makar K
Moore PL
Giiser network
Trends Microbiol, (2025). 33:1150-1154
The impact of 10-valent pneumococcal conjugate vaccine on the incidence of admissions to hospital with hypoxaemic and non-hypoxaemic pneumonia in Kenyan children.Haeusler IL
Kagucia EW
Bottomley C
Otiende M
Nyiro J
Scott JAG
PLOS Glob Public Health, (2025). 5:e0004888
Addressing the challenges of estimating the target population in calculation of routine infant immunization coverage in Kenya.Karanja-Chege C
Agweyu A
Were F
Boele van Hensbroek M
Ogallo W
PLOS Glob Public Health, (2025). 5:e0004298
Implementing community-based interventions for the management of chronic conditions in low- and middle-income countries: A scoping review of qualitative evidence.Hassan S
Kagwanja N
Diallo B
Oyando R
Perel P
Etyang A
Tsofa B
Nolte E
IHCoR-Africa Collaborators
PLOS Glob Public Health, (2025). 5:e0004860
Lessons learnt during establishment of COVID-19 active vaccine safety surveillance in nine African countries.Cutland CL
Gutu K
Yun JA
Izu A
Mahtab S
Peter J
Ansah NA
Obaro S
Tilahun B
Jambo K
Sow S
Kagucia EW
Chicumbe S
Dlamini T
Browne M
Clothier H
Griffin J
Jiang Y
Lee A
Ghebreab L
Madhi SA
Black SB
Active vaccine safety surveillance team
Vaccine, (2025). 62:127441
Trials for LLM-supported clinical decisions in African primary healthcare.Mateen BA
Menon V
Agweyu A
Korom R
Omoluabi E
McAfee D
Shimelash N
Rutunda S
Rugege C
Williams G
Emmanuel-Fabula M
Denniston AK
Liu X
Miles M
Nat Med, (2025). 31:2833-2835
Single low dose primaquine to block the transmission of Plasmodium falciparum-proposed stand-alone and ACT-adapted regimens.Taylor WRJ
Olupot-Olupot P
Onyamboko MA
Chimjinda N
Taya C
Pouplin JNN
Williams TN
Maitland K
Fanello CA
Day NPJ
Tarning J
White NJ
Mukaka M
BMC Med, (2025). 23:397
Early weaning from oxygen therapy in African children with severe pneumonia.Maitland K
Giallongo E
Hamaluba M
Alaroker F
Opoka RO
Tagoola A
Nalwanga D
Nabawanuka E
Okiror W
Nakuya M
Aromut D
Williams TN
Thomas K
Harrison DA
Mouncey P
Bush A
Fraser JF
Rowan K
Olupot-Olupot P
Kiguli S
Coast trial group
BMC Med, (2025). 23:366
GRAPEVNE - Graphical Analytical Pipeline Development Environment for Infectious Diseases.Brittain JS
Tsui J
Inward R
Gutierrez B
Mwanyika G
Tegally H
Huynh T
Githinji G
Tessema SK
McCrone JT
Bhatt S
Dasgupta A
Ratcliffe S
Kraemer MUG
Wellcome Open Res, (2025). 10:279
Emergence and transmission dynamics of the FY.4 Omicron variant in Kenya.Musundi S
Mwanga M
Lambisia A
Morobe JM
Murunga N
Moraa E
Ndwiga L
Cheruiyot R
Musyoki J
Mutunga M
Guzman-Rincon LM
Sande C
Mwangangi J
Bejon P
Ochola-Oyier LI
Nokes DJ
Agoti CN
Nyiro J
Githinji G
Virus Evol, (2025). 11:veaf035
Deploying Metagenomics to Characterize Microbial Pathogens During Outbreak of Acute Febrile Illness Among Children in Tanzania.Mziray SR
Githinji G
de Laurent ZR
Mbelele PM
Mohammed KS
Wadugu BD
Grundy BS
Heysell SK
Mpagama SG
Chilongola JO
Pathogens, (2025). 14:
Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009-2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016.Mburu CN
Ojal J
Selim R
Ombati R
Akech D
Karia B
Tuju J
Sigilai A
Smits G
van Gageldonk PGM
van der Klis FRM
Flasche S
Kagucia EW
Scott JAG
Adetifa IMO
Vaccine, (2025). 61:127425
